Ziopharm Oncology, Inc. has appointed Satyavrat “Sath” Shukla, CFA, as the Company’s Chief Financial Officer. He will direct all financial planning, analysis and reporting, treasury and tax functions, and will take on a key leadership role in the company’s capital strategy development and investor relations activities.   Mr. Shukla brings 20 years of strategic corporate and financial leadership experience. He was most recently Vice President and global Head of Corporate Finance for Verte...